ArticleEndocrine, metabolic & immune disorders drug targets2026
Global Scientific Trends in the Use of Mesenchymal Stem Cells for the Treatment of Diabetes Mellitus from 2000 to 2023: A Bibliometric Study
Zhenquan Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.